(E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate
Names | |
---|---|
IUPAC name
(E)-4-hydroxy-3-methylbut-2-enoxy-oxidophosphoryl phosphate
|
|
Other names
(E)-4-hydroxy-dimethylallyl pyrophosphate
HDMAPP (E)-4-Hydroxy-3-methyl-but-2-enyl diphosphate HMBDP |
|
Identifiers | |
ChEBI | CHEBI:15664 |
ChEMBL | ChEMBL145233 |
ChemSpider | 4445244 |
Jmol 3D model | Interactive image Interactive image |
PubChem | 21597501 |
|
|
|
|
Properties | |
C5H12O8P2 | |
Molar mass | 262.09 g·mol−1 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
(E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP or HMB-PP) is an intermediate of the MEP pathway (non-mevalonate pathway) of isoprenoid biosynthesis.[1][2] The enzyme HMB-PP synthase (GcpE, IspG) catalyzes the conversion of 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MEcPP) into HMB-PP. HMB-PP is then converted further to isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) by HMB-PP reductase (LytB, IspH).
HMB-PP is an essential metabolite in most pathogenic bacteria including Mycobacterium tuberculosis as well as in malaria parasites, but is absent from the human host.[3]
HMB-PP is the physiological activator ("phosphoantigen") for human Vγ9/Vδ2 T cells, the major γδ T cell population in peripheral blood. With a bioactivity of 0.1 nM it is 10,000-10,000,000 times more potent than any other natural compound, such as IPP or alkyl amines. HMB-PP functions in this capacity by binding the B30.2 domain of BTN3A1.[4]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
- 4-hydroxy-3-methylbut-2-enyl pyrophosphate at the US National Library of Medicine Medical Subject Headings (MeSH)